Home > Result Summaries: Compounds > verucerfont Result Summaries: verucerfont GSKStudy ID Phase Title Summary (Download) 106139 phase 2 A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed with Major Depressive Disorder (0 citation(s)) CRS 105510 phase 1 A randomised, placebo-controlled, double-dummy, crossover design study to investigate the changes of fMRI BOLD activation induced by emotional activation paradigms following single doses of GSK561679 and lorazepam (comparator) in healthy subjects (0 citation(s))
